UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 585

Sortiert nach

Stereo‐Selective Metabolism of Methadone by Human Liver Microsomes and cDNA‐Expressed Cytochrome P450s: A Reconciliation

Basic & clinical pharmacology & toxicology, 2011-01, Vol.108 (1), p.55-62

2011

Link zum Volltext

Verfügbarkeit prüfen

Azole Antifungal Inhibition of Buprenorphine, Methadone and Oxycodone In Vitro Metabolism

Journal of analytical toxicology, 2015-06, Vol.39 (5), p.374-386

2015

Link zum Volltext

Verfügbarkeit prüfen

Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids

Drug and alcohol dependence, 2015-08, Vol.153, p.306-313

2015

Link zum Volltext

Verfügbarkeit prüfen

Interaction between buprenorphine and atazanavir or atazanavir/ritonavir

Drug and alcohol dependence, 2007-12, Vol.91 (2), p.269-278

2007

Link zum Volltext

Verfügbarkeit prüfen

Novel metabolites of buprenorphine detected in human liver microsomes and human urine

Drug metabolism and disposition, 2006-03, Vol.34 (3), p.440

2006

Link zum Volltext

Verfügbarkeit prüfen

The inhibition of first-pass metabolism of ethanol by H 2 -receptor antagonists: a tabulated review

Expert opinion on drug safety, 2018-09, Vol.17 (9), p.917-934

Moody, David E

2018

Link zum Volltext

Verfügbarkeit prüfen

Could Postnatal Age–Related Uridine Diphosphate Glucuronic Acid Be a Rate‐Limiting Factor in the Metabolism of Morphine During the First Week of Life?

CPT: pharmacometrics and systems pharmacology, 2019-07, Vol.8 (7), p.469-477

2019

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Recent Cocaine Use on Plasma Levels of Methadone and Buprenorphine in Patients with and Without HIV-infection

Journal of substance abuse treatment, 2015-04, Vol.51, p.70-74

2015

Link zum Volltext

Verfügbarkeit prüfen

Metabolism of Capsaicin by Cytochrome P450 Produces Novel Dehydrogenated Metabolites and Decreases Cytotoxicity to Lung and Liver Cells

Chemical research in toxicology, 2003-03, Vol.16 (3), p.336-349

2003

Link zum Volltext

Verfügbarkeit prüfen

Gender differences in pharmacokinetics of maintenance dosed buprenorphine

Drug and alcohol dependence, 2011-11, Vol.118 (2), p.479-483

2011

Link zum Volltext

Verfügbarkeit prüfen

Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine

Expert opinion on drug metabolism & toxicology, 2013-06, Vol.9 (6), p.675-697

Moody, David E

2013

Link zum Volltext

Verfügbarkeit prüfen

Seven misconceptions regarding the Gaia hypothesis

Climatic change, 2012-07, Vol.113 (2), p.277-284

Moody, David E.

2012

Link zum Volltext

Verfügbarkeit prüfen

A reduced complexity cross between BALB/c substrains identifies Zhx2 as a candidate gene underlying oxycodone metabolite brain concentration and state‐dependent learning of opioid reward

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Analysis for Alpha-Pyrrolidinovalerophenone and Its 2-Oxo-PVP Metabolite in Plasma by Liquid Chromatography–Tandem Mass Spectrometry

Journal of analytical toxicology, 2021-02, Vol.45 (1), p.21-27

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes

Drug metabolism and disposition, 2009-12, Vol.37 (12), p.2323

2009

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of In Vitro Metabolism of Opioids by Skeletal Muscle Relaxants

Basic & clinical pharmacology & toxicology, 2018-09, Vol.123 (3), p.327-334

2018

Link zum Volltext

Verfügbarkeit prüfen

Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward

The Journal of pharmacology and experimental therapeutics, 2022-08, Vol.382 (2), p.167

2022

Link zum Volltext

Verfügbarkeit prüfen

The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome

Clinical pharmacology and therapeutics, 2018-06, Vol.103 (6), p.1029-1037

2018

Link zum Volltext

Verfügbarkeit prüfen

Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial

Drug and alcohol dependence, 2018-08, Vol.189, p.30-36

2018

Link zum Volltext

Verfügbarkeit prüfen

The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers

Addiction (Abingdon, England), 2011-08, Vol.106 (8), p.1460-1473

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes

European journal of clinical pharmacology, 2005-02, Vol.60 (12), p.875-881

2005

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Buprenorphine and Sustained-release Buprenorphine in Common Marmosets (Callithrix jacchus)

Journal of the American Association for Laboratory Animal Science, 2021-03, Vol.60 (2), p.188-194

2021

Link zum Volltext

Verfügbarkeit prüfen

Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

Pharmacotherapy, 2015-07, Vol.35 (7), p.670-680

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Single-Dose Intramuscular and Subcutaneous Injections of Buprenorphine in Common Marmosets (Callithrix jacchus)

Journal of the American Association for Laboratory Animal Science, 2021-09, Vol.60 (5), p.568-575

2021

Link zum Volltext

Verfügbarkeit prüfen

Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment

Journal of clinical psychopharmacology, 2016-08, Vol.36 (4), p.347-354

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 585

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(495)
Mit Volltextzugriff
(513)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Stereo‐Selective Metabolism of Methadone by Human Liver Microsomes and cDNA‐Expressed Cytochrome P450s: A Reconciliation

Azole Antifungal Inhibition of Buprenorphine, Methadone and Oxycodone In Vitro Metabolism

Application of programmable bio-nano-chip system for the quantitative detection of drugs of abuse in oral fluids

Interaction between buprenorphine and atazanavir or atazanavir/ritonavir

Novel metabolites of buprenorphine detected in human liver microsomes and human urine

The inhibition of first-pass metabolism of ethanol by H 2 -receptor antagonists: a tabulated review

Could Postnatal Age–Related Uridine Diphosphate Glucuronic Acid Be a Rate‐Limiting Factor in the Metabolism of Morphine During the First Week of Life?

The Impact of Recent Cocaine Use on Plasma Levels of Methadone and Buprenorphine in Patients with and Without HIV-infection

Metabolism of Capsaicin by Cytochrome P450 Produces Novel Dehydrogenated Metabolites and Decreases Cytotoxicity to Lung and Liver Cells

Gender differences in pharmacokinetics of maintenance dosed buprenorphine

Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine

Seven misconceptions regarding the Gaia hypothesis

A reduced complexity cross between BALB/c substrains identifies Zhx2 as a candidate gene underlying oxycodone metabolite brain concentration and state‐dependent learning of opioid reward

Analysis for Alpha-Pyrrolidinovalerophenone and Its 2-Oxo-PVP Metabolite in Plasma by Liquid Chromatography–Tandem Mass Spectrometry

Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes

Inhibition of In Vitro Metabolism of Opioids by Skeletal Muscle Relaxants

Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward

The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome

Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial

The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers

Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes

Pharmacokinetics of Buprenorphine and Sustained-release Buprenorphine in Common Marmosets (Callithrix jacchus)

Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

Pharmacokinetics of Single-Dose Intramuscular and Subcutaneous Injections of Buprenorphine in Common Marmosets (Callithrix jacchus)

Safety of Intravenous Methamphetamine Administration During Ibudilast Treatment

Suchergebnisse filtern